GUIDELINES FOR THE PREVENTION, DETECTION AND THERAPY OF VITAMIN D DEFICIENCY IN ADULTS.
暂无分享,去创建一个
M. B. Pašić | Ž. Reiner | B. Anić | E. Vrdoljak | Marija Bošnjak Pašić | V. Kušec | Ž. Krznarić | D. Vranešić Bender | N. L. Žerjavić | Z. Giljević | N. Laktašić Žerjavić | Lkinas Kelećić Dina | D. Bender | V. Kušec | Edvard Vrdoljak | Dina Lukinac Kelećić
[1] N. Dabelić,et al. Bone health and adherence to vitamin D and calcium therapy in early breast cancer patients on endocrine therapy with aromatase inhibitors. , 2017, Breast.
[2] A. Sahebkar,et al. Impact of Statin Therapy on Plasma Vitamin D Levels: A Systematic Review and Meta-Analysis. , 2017, Current pharmaceutical design.
[3] David A. Jolliffe,et al. Single nucleotide polymorphisms in the vitamin D pathway associating with circulating concentrations of vitamin D metabolites and non-skeletal health outcomes: Review of genetic association studies , 2016, The Journal of Steroid Biochemistry and Molecular Biology.
[4] J. Damoiseaux,et al. A low vitamin D status at diagnosis is associated with an early conversion to secondary progressive multiple sclerosis , 2016, The Journal of Steroid Biochemistry and Molecular Biology.
[5] C. Mantzoros,et al. Hypovitaminosis D in bariatric surgery: A systematic review of observational studies. , 2016, Metabolism: clinical and experimental.
[6] J. Damoiseaux,et al. Illuminating vitamin D effects on B cells – the multiple sclerosis perspective , 2016, Immunology.
[7] Weiqian Chen,et al. Serum Vitamin D Level and Rheumatoid Arthritis Disease Activity: Review and Meta-Analysis , 2016, PloS one.
[8] D. Harvey,et al. Vitamin D Status and Rates of Cognitive Decline in a Multiethnic Cohort of Older Adults. , 2015, JAMA neurology.
[9] A. Szymczak,et al. The importance of vitamin D in the pathology of bone metabolism in inflammatory bowel diseases , 2015, Archives of medical science : AMS.
[10] Junxia Yang,et al. Effect of vitamin D on the recurrence rate of rheumatoid arthritis , 2015, Experimental and therapeutic medicine.
[11] A. Ponsonby,et al. Analytical Bias in the Measurement of Serum 25-Hydroxyvitamin D Concentrations Impairs Assessment of Vitamin D Status in Clinical and Research Settings , 2015, PloS one.
[12] W. Lems,et al. Bisphosphonates and glucocorticoid-induced osteoporosis: cons , 2015, Endocrine.
[13] C. Wolfson,et al. Timing of use of cod liver oil, a vitamin D source, and multiple sclerosis risk: The EnvIMS study , 2015, Multiple sclerosis.
[14] M. Eliades,et al. Vitamin D: a new player in non-alcoholic fatty liver disease? , 2015, World journal of gastroenterology.
[15] Y. Levy,et al. Vitamin D Antibodies in Systemic Sclerosis Patients: Findings and Clinical Correlations. , 2015, The Israel Medical Association journal : IMAJ.
[16] J. Payer,et al. Vitamin D therapy in inflammatory bowel diseases: who, in what form, and how much? , 2015, Journal of Crohn's & colitis.
[17] M. O'Sullivan. Vitamin D as a novel therapy in inflammatory bowel disease: new hope or false dawn? , 2014, Proceedings of the Nutrition Society.
[18] M. Aapro,et al. Bone health in cancer patients: ESMO Clinical Practice Guidelines. , 2014, Annals of oncology : official journal of the European Society for Medical Oncology.
[19] K. Madsen,et al. Vitamin D improves inflammatory bowel disease outcomes: basic science and clinical review. , 2014, World journal of gastroenterology.
[20] Amal M. H. Mackawy,et al. Vitamin d deficiency and its association with thyroid disease. , 2013, International journal of health sciences.
[21] S. Patten,et al. The case for vitamin D supplementation in multiple sclerosis. , 2013, Multiple sclerosis and related disorders.
[22] Zeng-li Zhang,et al. Vitamin D Intake and Risk of Type 1 Diabetes: A Meta-Analysis of Observational Studies , 2013, Nutrients.
[23] K. Robien,et al. Drug-vitamin D interactions: a systematic review of the literature. , 2013, Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition.
[24] C. Stokes,et al. Vitamin D in chronic liver disease , 2013, Liver international : official journal of the International Association for the Study of the Liver.
[25] H. Bischoff-Ferrari. Relevance of vitamin D in bone and muscle health of cancer patients. , 2012, Anti-cancer agents in medicinal chemistry.
[26] J. Manson,et al. Circulating 25-Hydroxy-Vitamin D and Risk of Cardiovascular Disease: A Meta-Analysis of Prospective Studies , 2012, Circulation. Cardiovascular quality and outcomes.
[27] M. Cantorna. Vitamin D, multiple sclerosis and inflammatory bowel disease. , 2012, Archives of biochemistry and biophysics.
[28] Lynette M. Smith,et al. Dose Response to Vitamin D Supplementation in Postmenopausal Women , 2012, Annals of Internal Medicine.
[29] M. Melamed,et al. Association of glucocorticoid use and low 25-hydroxyvitamin D levels: results from the National Health and Nutrition Examination Survey (NHANES): 2001-2006. , 2011, The Journal of clinical endocrinology and metabolism.
[30] M. Holick,et al. Vitamin D intoxication with severe hypercalcemia due to manufacturing and labeling errors of two dietary supplements made in the United States. , 2011, The Journal of clinical endocrinology and metabolism.
[31] Ž. Crnčević-Orlić,et al. VITAMIN D: VITAMIN PROŠLOSTI, HORMON BUDUĆNOSTI , 2011 .
[32] C. Gordon,et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. , 2011, The Journal of clinical endocrinology and metabolism.
[33] Y. Shoenfeld,et al. Vitamin D and autoimmune thyroid diseases , 2011, Cellular and Molecular Immunology.
[34] J. Manson,et al. Vitamin D and prevention of cancer--ready for prime time? , 2011, The New England journal of medicine.
[35] S. Pilz,et al. Role of vitamin D in arterial hypertension , 2010, Expert review of cardiovascular therapy.
[36] J. Simpson,et al. Annual high-dose oral vitamin D and falls and fractures in older women: a randomized controlled trial. , 2010, JAMA.
[37] Y. Shoenfeld,et al. Serum concentrations of 25-OH vitamin D in patients with systemic lupus erythematosus (SLE) are inversely related to disease activity: is it time to routinely supplement patients with SLE with vitamin D? , 2010, Annals of the rheumatic diseases.
[38] O. Polašek,et al. Vitamin D status, dependence on age, and seasonal variations in the concentration of vitamin D in Croatian postmenopausal women initially screened for osteoporosis , 2010, Clinical Rheumatology.
[39] J. Adachi,et al. Glucocorticoid-induced osteoporosis: treatment update and review , 2009, Therapeutic advances in musculoskeletal disease.
[40] T. Pieber,et al. Vitamin D status and arterial hypertension: a systematic review , 2009, Nature Reviews Cardiology.
[41] P. Menheere,et al. The relevance of vitamin D receptor gene polymorphisms for vitamin D research in multiple sclerosis. , 2009, Autoimmunity reviews.
[42] M. Holick. The vitamin D deficiency pandemic and consequences for nonskeletal health: mechanisms of action. , 2008, Molecular aspects of medicine.
[43] Jeanne M Clark,et al. The epidemiology of nonalcoholic fatty liver disease: a global perspective. , 2008, Seminars in liver disease.
[44] S. Ish-shalom,et al. Comparison of daily, weekly, and monthly vitamin D3 in ethanol dosing protocols for two months in elderly hip fracture patients. , 2008, The Journal of clinical endocrinology and metabolism.
[45] B. Nakken,et al. The Complex Role of Vitamin D in Autoimmune Diseases , 2008, Scandinavian journal of immunology.
[46] L. Adorini,et al. Control of autoimmune diseases by the vitamin D endocrine system , 2008, Nature Clinical Practice Rheumatology.
[47] J. Bilezikian,et al. Glucocorticoid-induced osteoporosis: pathophysiology and therapy , 2007, Osteoporosis International.
[48] C. Gordon,et al. Report on the vitamin D status of adult and pediatric patients with inflammatory bowel disease and its significance for bone health and disease , 2006, Inflammatory bowel diseases.
[49] M. Holick. Resurrection of vitamin D deficiency and rickets. , 2006, The Journal of clinical investigation.
[50] John Robbins,et al. Calcium plus vitamin D supplementation and the risk of colorectal cancer. , 2006, The New England journal of medicine.
[51] C. Cooper,et al. A simple score for estimating the long-term risk of fracture in patients using oral glucocorticoids. , 2005, QJM : monthly journal of the Association of Physicians.
[52] L. Mosekilde. Vitamin D and the elderly , 2005, Clinical endocrinology.
[53] H. Stähelin,et al. A new significant and independent risk factor for falls in elderly men and women: a low creatinine clearance of less than 65 ml/min , 2005, Osteoporosis International.
[54] Yan Zhu,et al. Vitamin D status, 1,25-dihydroxyvitamin D3, and the immune system. , 2004, The American journal of clinical nutrition.
[55] C. Polman,et al. Multiple sclerosis and vitamin D: an update , 2004, European Journal of Clinical Nutrition.
[56] B. Dawson-Hughes,et al. Serum 25-hydroxyvitamin D status of adolescents and adults in two seasonal subpopulations from NHANES III. , 2002, Bone.
[57] Elina Hyppönen,et al. Intake of vitamin D and risk of type 1 diabetes: a birth-cohort study , 2001, The Lancet.
[58] H. Glerup,et al. Commonly recommended daily intake of vitamin D is not sufficient if sunlight exposure is limited , 2000, Journal of internal medicine.
[59] M. Holick,et al. AGE, VITAMIN D, AND SOLAR ULTRAVIOLET , 1989, The Lancet.
[60] P. Goldberg,et al. Multiple sclerosis: decreased relapse rate through dietary supplementation with calcium, magnesium and vitamin D. , 1986, Medical hypotheses.
[61] C. Christiansen,et al. Regulation of vitamin D and calcium metabolism after gastrectomy. , 1985, Gut.
[62] M. Lilburn,et al. 25-Hydroxycholecalciferol absorption in steatorrhoea and postgastrectomy osteomalacia. , 1977, British medical journal.
[63] R. L. Eddy. Metabolic bone disease after gastrectomy. , 1971, The American journal of medicine.
[64] E. Acheson,et al. SOME COMMENTS ON THE RELATIONSHIP OF THE DISTRIBUTION OF MULTIPLE SCLEROSIS TO LATITUDE, SOLAR RADIATION, AND OTHER VARIABLES , 1960, Acta psychiatrica Scandinavica. Supplementum.
[65] Karen S Henry,et al. American Cancer Society/American Society of Clinical Oncology Breast Cancer Survivorship Care Guideline , 2015 .
[66] L. Fonseca,et al. Vitamin D: non-skeletal actions and rational use. , 2013 .
[67] G. Rebecca,et al. American College of Rheumatology 2010 Recommendations for the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis , 2011 .
[68] Christine L. Taylor,et al. Committee to Review Dietary Reference Intakes for Vitamin D and Calcium , 2011 .
[69] B. Kestenbaum,et al. Calcium plus vitamin D supplementation and the risk of incident diabetes mellitus in the Women ’ s Health Initiative , 2008 .
[70] K. Helzlsouer. American Journal of Epidemiology Original Contribution Overview of the Cohort Consortium Vitamin D Pooling Project of Rarer Cancers , 2022 .